NCT02147600View on ClinicalTrials.gov

Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

January 9, 2014

Primary Completion Date

April 10, 2014

Study Completion Date

April 10, 2014

Conditions
Psoriasis
Trial Locations (5)

2400

H Hart Hospital, Mol

8820

ST Rembert Hospital, Torhout

9000

Ghent University, Dpt. of Dermatology, Ghent

Maria Middelares Hospital, Ghent

St. Lucas Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT02147600 - Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients | Biotech Hunter | Biotech Hunter